Skvarka Jan 4
4 · Monte Rosa Therapeutics, Inc. · Filed Mar 31, 2023
Insider Transaction Report
Form 4
Skvarka Jan
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-30+41,000→ 41,000 totalExercise: $7.36Exp: 2033-03-29→ Common Stock (41,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 36 substantially equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.